These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1203 related articles for article (PubMed ID: 34102931)

  • 1. Rosuvastatin and ezetimibe for the treatment of dyslipidemia and hypercholesterolemia.
    Boutari C; Karagiannis A; Athyros VG
    Expert Rev Cardiovasc Ther; 2021 Jul; 19(7):575-580. PubMed ID: 34102931
    [No Abstract]   [Full Text] [Related]  

  • 2. An overview of rosuvastatin/ezetimibe association for the treatment of hypercholesterolemia and mixed dyslipidemia.
    Strilchuk L; Tocci G; Fogacci F; Cicero AFG
    Expert Opin Pharmacother; 2020 Apr; 21(5):531-539. PubMed ID: 32036729
    [No Abstract]   [Full Text] [Related]  

  • 3. Rosuvastatin/Ezetimibe: A Review in Hypercholesterolemia.
    Lamb YN
    Am J Cardiovasc Drugs; 2020 Aug; 20(4):381-392. PubMed ID: 32648167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Fixed-dose Combination of Low-intensity Rosuvastatin and Ezetimibe Versus Moderate-intensity Rosuvastatin Monotherapy on Lipid Profiles in Patients With Hypercholesterolemia: A Randomized, Double-blind, Multicenter, Phase III Study.
    Lee SA; Kim W; Hong TJ; Ahn Y; Kim MH; Hong SJ; Kim BS; Kim SY; Chae IH; Kim BJ; Rhee MY; Shin JH; Kang TS; Cho JM; Kim JS; Lee CW
    Clin Ther; 2021 Sep; 43(9):1573-1589. PubMed ID: 34429197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial.
    Hong SJ; Jeong HS; Ahn JC; Cha DH; Won KH; Kim W; Cho SK; Kim SY; Yoo BS; Sung KC; Rha SW; Shin JH; Han KR; Chung WS; Hyon MS; Lee HC; Bae JH; Rhee MY; Kwan J; Jeon DW; Yoo KD; Kim HS
    Clin Ther; 2018 Feb; 40(2):226-241.e4. PubMed ID: 29402522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination Therapy of Ezetimibe and Rosuvastatin for Dyslipidemia: Current Insights.
    Chilbert MR; VanDuyn D; Salah S; Clark CM; Ma Q
    Drug Des Devel Ther; 2022; 16():2177-2186. PubMed ID: 35832642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial.
    Robinson JG; Nedergaard BS; Rogers WJ; Fialkow J; Neutel JM; Ramstad D; Somaratne R; Legg JC; Nelson P; Scott R; Wasserman SM; Weiss R;
    JAMA; 2014 May; 311(18):1870-82. PubMed ID: 24825642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fixed-dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS-ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe).
    Kim KJ; Kim SH; Yoon YW; Rha SW; Hong SJ; Kwak CH; Kim W; Nam CW; Rhee MY; Park TH; Hong TJ; Park S; Ahn Y; Lee N; Jeon HK; Jeon DW; Han KR; Moon KW; Chae IH; Kim HS
    Cardiovasc Ther; 2016 Oct; 34(5):371-82. PubMed ID: 27506635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed-dose combination of rosuvastatin and ezetimibe: treating hypercholesteremia according to cardiovascular risk.
    Barrios V; Escobar C
    Expert Rev Clin Pharmacol; 2021 Jul; 14(7):793-806. PubMed ID: 33970743
    [No Abstract]   [Full Text] [Related]  

  • 10. The impact of the time of drug administration on the effectiveness of combined treatment of hypercholesterolemia with Rosuvastatin and Ezetimibe (RosEze): study protocol for a randomized controlled trial.
    Obońska K; Kasprzak M; Sikora J; Obońska E; Racki K; Goździkiewicz N; Krintus M; Kubica J
    Trials; 2017 Jul; 18(1):316. PubMed ID: 28697767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezetimibe in high-risk, previously treated statin patients: a systematic review and network meta-analysis of lipid efficacy.
    Lorenzi M; Ambegaonkar B; Baxter CA; Jansen J; Zoratti MJ; Davies G
    Clin Res Cardiol; 2019 May; 108(5):487-509. PubMed ID: 30302558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom.
    Cao X; Ejzykowicz F; Ramey DR; Sajjan S; Ambegaonkar BM; Mavros P; Tunceli K
    Clin Ther; 2015 Apr; 37(4):804-15. PubMed ID: 25626487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LDL Cholesterol Reduction Variability with Different Types and Doses of Statins in Monotherapy or Combined with Ezetimibe. Results from the Spanish Arteriosclerosis Society Dyslipidaemia Registry.
    Climent E; Bea AM; Benaiges D; Brea-Hernando Á; Pintó X; Suárez-Tembra M; Perea V; Plana N; Blanco-Vaca F; Pedro-Botet J;
    Cardiovasc Drugs Ther; 2022 Apr; 36(2):301-308. PubMed ID: 33555511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients.
    Saeedi R; Johns K; Frohlich J; Bennett MT; Bondy G
    Lipids Health Dis; 2015 Jun; 14():57. PubMed ID: 26087958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis.
    Ambegaonkar BM; Tipping D; Polis AB; Tomassini JE; Tershakovec AM
    Atherosclerosis; 2014 Dec; 237(2):829-37. PubMed ID: 25463129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Dyslipidemia Control by Combination Therapy with Rosuvastatin 10 Mg and Ezetimibe 10 Mg Compared with Rosuvastatin 20 Mg Monotherapy in Patients with Chronic Coronary Syndromes: A Randomized, Single-blind Controlled Trial.
    Tran AV; Tran BLT; Bui NM; Le ATT; Nguyen DT; Tran SK; Ngo TH
    Cardiovasc Hematol Agents Med Chem; 2024; 22(3):390-398. PubMed ID: 38275031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination Therapy of Rosuvastatin and Ezetimibe in Patients with High Cardiovascular Risk.
    Yang YJ; Lee SH; Kim BS; Cho YK; Cho HJ; Cho KI; Kim SY; Ryu JK; Cho JM; Park JI; Park JS; Park CG; Chun WJ; Kim MA; Jin DK; Lee N; Kim BJ; Koh KK; Suh J; Lee SH; Lee BK; Oh SJ; Jin HY; Ahn Y; Lee SG; Bae JH; Park WJ; Lee SC; Lee HC; Lee J; Park C; Lee B; Jang Y
    Clin Ther; 2017 Jan; 39(1):107-117. PubMed ID: 28007331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the efficacy and safety of atorvastatin + ezetimibe in a fixed-dose combination for the treatment of hypercholesterolemia.
    Ma YB; Chan P; Zhang Y; Tomlinson B; Liu Z
    Expert Opin Pharmacother; 2019 Jun; 20(8):917-928. PubMed ID: 30908086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Adherence to Free and Single-Pill Combination of Rosuvastatin/Ezetimibe: Findings from a Real-World Analysis in Italy.
    Perez de Isla L; Liberopoulos E; Dovizio M; Veronesi C; Degli Esposti L; Zambon A
    Adv Ther; 2024 Aug; 41(8):3407-3418. PubMed ID: 38963586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ezetimibe-rosuvastatin fixed-dose combination (Myrosor®)].
    Wallemacq C; Scheen AJ
    Rev Med Liege; 2020 Apr; 75(4):260-264. PubMed ID: 32267116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.